Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
about
RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolismPDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathwayStructural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C-terminusHyperosmotic stress-induced ATF-2 activation through Polo-like kinase 3 in human corneal epithelial cellsCCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesisCHIP-dependent termination of MEKK2 regulates temporal ERK activation required for proper hyperosmotic responseRole of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathwaysCharacterization of a novel low-molecular-mass dual-specificity phosphatase-3 (LDP-3) that enhances activation of JNK and p38Mutations within the programmed cell death 10 gene cause cerebral cavernous malformationsIdentification of protein interactions involved in cellular signalingBrx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5MKP-1 inhibits high NaCl-induced activation of p38 but does not inhibit the activation of TonEBP/OREBP: opposite roles of p38alpha and p38deltaHow do kinases contribute to tonicity-dependent regulation of the transcription factor NFAT5?Dynamic regulation of aquaporin-4 water channels in neurological disordersCerebral cavernous malformation is a vascular disease associated with activated RhoA signalingVascular anomalies: from genetics toward models for therapeutic trialsMicro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient MiceThe p38/MK2/Hsp25 pathway is required for BMP-2-induced cell migrationAdaptor protein Ste50p links the Ste11p MEKK to the HOG pathway through plasma membrane association.A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in α1-adrenergic receptor-induced p38 activationRho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.Trophoblast stem cell maintenance by fibroblast growth factor 4 requires MEKK4 activation of Jun N-terminal kinasePAK is regulated by PI3K, PIX, CDC42, and PP2Calpha and mediates focal adhesion turnover in the hyperosmotic stress-induced p38 pathwayStructural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutationsKLF4 is a key determinant in the development and progression of cerebral cavernous malformations.Phosphorylation sites in the cerebral cavernous malformations complexHyperosmotic stress signaling to the nucleus disrupts the Ran gradient and the production of RanGTPLaser-scanning velocimetry: a confocal microscopy method for quantitative measurement of cardiovascular performance in zebrafish embryos and larvaeHydroxyurea exposure triggers tissue-specific activation of p38 mitogen-activated protein kinase signaling and the DNA damage response in organogenesis-stage mouse embryos.Loss of Arp2/3 induces an NF-κB-dependent, nonautonomous effect on chemotactic signalingCoordination of satellite cell activation and self-renewal by Par-complex-dependent asymmetric activation of p38α/β MAPKComputational model explains high activity and rapid cycling of Rho GTPases within protein complexesMouse preimplantation embryo responses to culture medium osmolarity include increased expression of CCM2 and p38 MAPK activationThe neogenin intracellular domain regulates gene transcription via nuclear translocation.Cerebral cavernous malformation: new molecular and clinical insights.Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.Safeguarding entry into mitosis: the antephase checkpoint.Biology of vascular malformations of the brain.Rac1 mediates NaCl-induced superoxide generation in the thick ascending limb.Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysis.
P2860
Q21145250-F602C6C3-9A40-4E11-AFCE-6D382F986881Q24300270-E12F1D4A-3575-4457-9D84-C50DA5164C05Q24307063-D50CD58E-434B-46A1-BAF2-E56D67BC0790Q24307842-6A9F2F3D-5A83-4F70-93A3-5544D899716CQ24309334-C9DF8E2A-6A21-4313-A396-DD153DCB3C91Q24336920-A7435D0D-298D-40CA-9BBB-519E4184FAA9Q24519085-2C413B2C-1448-4B41-874B-E7D49B5BB8DEQ24528106-5F0BEA93-23B2-4F9B-A487-9B040A718B1EQ24530747-A2294D91-BCD6-4EA9-BD15-668883EAC210Q24601574-436FD9BE-5668-4ECD-8DBE-7A090C394E57Q24634561-6C0193C8-F24F-4A6A-B15D-8E0CB750F2CAQ24657455-2B8AC95F-C197-4159-825A-757B23177182Q26770757-13690376-BC66-48E2-B379-36491F4B808AQ26777349-7E2C5E09-6EAE-40BE-9EB3-ABF342B72C53Q26849566-571054A7-494C-45DA-9F3A-7873EF96EBBCQ27025402-CD7961F6-698B-4CDD-8605-095199F7AE87Q27329910-D446819E-8AF8-4268-A13F-BE5940D30843Q27437628-657FA1AD-CB6E-4B48-9795-E6E7D13382A9Q27939643-BF9C6F3F-5DB9-42A8-BD98-06397B67D052Q28115053-B2F79420-3F38-410C-8A5C-9070A90EC8CDQ28274176-90FACA33-788E-491E-AD3F-DF873724583FQ28505246-76D12F8B-3E56-4A5D-8E9D-CFE79D1B6E22Q28582141-A8FA9E46-3A32-47B9-977F-7A8F55B3BB3EQ28650470-00EEEABA-E605-4AF0-B8E7-8498C16D609DQ30278010-1F88CF54-16B2-4D06-9BDB-EBB92A151D44Q30423675-112D3114-E783-4EA4-A82D-5B3C37DF2DC0Q30444083-79DE7689-6CE5-4446-AFBB-4A34B26B96BFQ30479978-F85AB7D4-8672-4026-AD04-C080CF92F635Q30540055-D03360CA-3515-4DD2-B1EC-4F0F1A367279Q30560511-3272D30F-D9AF-42DA-BE31-98932E88703BQ30582181-2D1D1452-807C-48E8-9FB3-30C27138B87BQ33265219-BD696D5D-E3B9-487C-A76D-C37FBB53B9EBQ33268789-A22E8317-34D4-464B-A870-67F863C5E6E5Q33327050-E4F6B1BC-9785-4119-BD04-1AA3DB840E5EQ33342264-13F4BAAE-3686-46D2-BDC8-79182663D961Q33348515-3D7822C6-F30D-4AA8-821A-7C6DC97B8A03Q33558235-B6C17F8B-A795-4158-A6D5-5D39453E6BBEQ33606813-5C2EA77E-A9D9-48BB-87C3-6403A2F13B0BQ33655668-C64BBEB0-F39F-47D6-8526-23E235CCBB4DQ33707224-57B5CA71-4A8E-458D-9BC3-64060091FF84
P2860
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@ast
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@en
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@nl
type
label
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@ast
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@en
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@nl
prefLabel
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@ast
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@en
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.
@nl
P2093
P356
P1433
P1476
Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock
@en
P2093
Amy N Abell
Bruce D Cuevas
Eric A Horne
Gary L Johnson
Katherine E Lobel-Rice
Mark T Uhlik
Nancy L Johnson
Weiyong Sun
P2888
P304
P356
10.1038/NCB1071
P577
2003-11-23T00:00:00Z
P5875
P6179
1031905902